Sampson, Christopher James http://orcid.org/0000-0001-9470-2369
Arnold, Renée http://orcid.org/0000-0001-5935-3220
Bryan, Stirling http://orcid.org/0000-0001-7093-3058
Clarke, Philip http://orcid.org/0000-0002-7555-5348
Ekins, Sean http://orcid.org/0000-0002-5691-5790
Hatswell, Anthony http://orcid.org/0000-0003-1129-326X
Hawkins, Neil http://orcid.org/0000-0003-3199-221X
Langham, Sue http://orcid.org/0000-0003-2088-3333
Marshall, Deborah http://orcid.org/0000-0002-8467-8008
Sadatsafavi, Mohsen http://orcid.org/0000-0002-0419-7862
Sullivan, Will http://orcid.org/0000-0001-5221-7074
Wilson, Edward C. F. http://orcid.org/0000-0002-8369-1577
Wrightson, Tim
Article History
First Online: 26 June 2019
Compliance with Ethical Standards
: No specific funding was received to support the preparation of this manuscript. CS is an employee of the Office of Health Economics, a registered charity, research organisation and consultancy, which receives funding from a variety of sources including the Association of the British Pharmaceutical Industry and the National Institute for Health Research (NIHR). CS has received honoraria from the NIHR in relation to peer review activities. CS has received travel support from Duke University for attendance at a meeting related to the content of this manuscript. SB receives salary support from the University of British Columbia, Vancouver Coastal Health and the British Columbia Academic Health Science Network. He previously chaired CADTH’s Health Technology Expert Review Panel and provides consultancy advice to CADTH, for which he received honoraria and travel support. All of his decision model project work is supported through public sources, primarily the Canadian Institutes for Health Research (CIHR) and the BC Ministry of Health. PC has received payment for workshops run alongside Mt Hood conferences. SE is CEO and Owner of Collaborations Pharmaceuticals, Inc. SE has received a grant from the National Institutes for Health to build machine learning models and software. DM is employed by the University of Calgary, with a salary funded by Arthur J.E. Child Chair in Rheumatology and Canada Research Chair in Health Systems and Services Research. DM’s research is funded through multiple funding organisations including the CIHR, Arthritis Society, CRA and AAC in peer-reviewed funding competitions, none of which relate to this work. DM has received reimbursement for travel from Illumina and Janssen for attendance and presentation at scientific meetings not related to this work. RA, AH, NH, SL, MS, WS, and EW declare that they have no conflicts of interest. TW is a Co-Editor of PharmacoEconomics, but was not involved in the peer review nor any editorial decisions for this paper.
: SE acknowledges funding from NIH/ NIGMS R43GM122196, R44GM122196-02A1.